Shares of Avidity Biosciences RNA rose more than 12% on Wednesday after the company announced that it is expanding its ...
Nearly three decades later, drug makers have developed six approved small interfering RNA (siRNA) therapeutics in the ...
Orna Therapeutics, part of a buzzy cohort of biotech companies established in the wake of the Covid pandemic, has cut more ...
Compared to DNA sequencing alone, concurrent DNA and RNA sequencing revealed more clinically actionable variants in NSCLC.
Zymo’s Quick DNA/RNA Viral MagBead Kit was automated using Analytik Jena’s Cybio FeliX pipetting robot. The CyBio FeliX ...
Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA ...
Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early ...
The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been ...
Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Buy rating on Avidity Biosciences (RNA – Research Report). The ...
An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...
A live webcast of the presentation can be accessed on the "Events & Presentations" page in the Investor section of Korro’s website at www.korrobio.com. Following the presentation, a replay of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback